Genemedics Health Institute

Genemedics Health Institute operates a physician-supervised clinic in Atlanta, GA, focusing on hormone optimization, metabolic health, and age management medicine. The practice combines hormone replacement therapy protocols with GLP-1 receptor agonist peptides for patients seeking comprehensive metabolic and endocrine support. All consultations occur in-person at the Atlanta location, where providers conduct initial assessments including laboratory analysis, body composition measurement, and medical history review before designing individualized treatment protocols.

The clinic prescribes four specific GLP-1 and dual-incretin peptides for weight management and metabolic optimization: Semaglutide (a GLP-1 agonist affecting appetite regulation and glucose metabolism), Tirzepatide (a dual GIP/GLP-1 receptor agonist with enhanced metabolic effects), Liraglutide (a once-daily GLP-1 analog used for weight management and glycemic control), and Retatrutide (a triple-incretin receptor agonist targeting GLP-1, GIP, and glucagon pathways). These peptides are integrated into broader treatment plans that may include bioidentical hormone replacement, nutritional protocols, and metabolic monitoring. Providers adjust peptide dosing based on patient response, tolerance, and laboratory markers tracked throughout treatment.

Genemedics Health Institute physicians hold credentials in age management medicine and hormone optimization, applying protocols that address andropause, menopause, thyroid dysfunction, and metabolic syndrome. The clinical approach involves serial hormone panels measuring testosterone, estradiol, progesterone, thyroid function, IGF-1, and metabolic markers to guide hormone replacement dosing. For patients combining hormone therapy with GLP-1 peptides, providers monitor for interactions affecting appetite, energy expenditure, and body composition changes. The Atlanta clinic maintains relationships with compounding pharmacies and specialty pharmacies to source peptides and bioidentical hormones according to individual prescriptions.

Patients beginning treatment at the Atlanta location undergo comprehensive intake appointments that include physical examination, review of current medications and supplements, discussion of treatment goals, and education about peptide administration techniques. For GLP-1 peptides requiring subcutaneous injection, staff provide injection training and supplies. Follow-up schedules typically include monthly check-ins during the initial treatment phase, with laboratory testing at 8-12 week intervals to assess hormone levels, metabolic markers, and treatment efficacy. The clinic tracks metrics including weight, body composition, fasting glucose, hemoglobin A1c, lipid panels, and hormone levels to document patient progress and adjust protocols.

Genemedics Health Institute differentiates itself in the Atlanta market through its focus on multi-system optimization rather than single-intervention approaches. Patients receive coordinated care addressing hormonal, metabolic, and age-related concerns within one practice. The clinic does not offer telehealth services, requiring all patients to attend in-person appointments at the Georgia location for examinations, consultations, and treatment monitoring. This in-person model allows for direct provider assessment, immediate adjustment of protocols, and hands-on patient education. The practice serves Atlanta residents and patients willing to travel to Georgia for specialized hormone and peptide therapy not readily available through conventional primary care channels.